克里唑蒂尼
医学
间变性淋巴瘤激酶
肺癌
不利影响
内科学
药理学
药代动力学
肿瘤科
恶性胸腔积液
作者
Andrew Timm,Jill Kolesar
摘要
Journal Article Crizotinib for the treatment of non-small-cell lung cancer Get access Andrew Timm, Andrew Timm Pharm.D. candidate School of Pharmacy, University of Wisconsin (UW)—Madison Search for other works by this author on: Oxford Academic Google Scholar Jill M. Kolesar, Pharm.D., FCCP Jill M. Kolesar, Pharm.D., FCCP Professor School of Pharmacy, UW—Madison, and Director, 3P Analytical Instrumentation Laboratory, UW Carbone Comprehensive Cancer Center Address correspondence to Dr. Kolesar at the Clinical Science Center, School of Pharmacy, University of Wisconsin, 600 Highland Avenue, K4/564, Madison, WI 53792 (jmkolesar@pharmacy.wisc.edu). Search for other works by this author on: Oxford Academic Google Scholar American Journal of Health-System Pharmacy, Volume 70, Issue 11, 1 June 2013, Pages 943–947, https://doi.org/10.2146/ajhp120261 Published: 01 June 2013
科研通智能强力驱动
Strongly Powered by AbleSci AI